What's new with stress ulcer prophylaxis in the ICU?

Intensive Care Med. 2017 Aug;43(8):1132-1134. doi: 10.1007/s00134-017-4733-0. Epub 2017 Feb 25.

Authors

Søren Marker¹, Mette Krag¹, Morten Hylander Møller²

Affiliations

¹ Department of Intensive Care, 4131, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, 2100, Copenhagen, Denmark.
² Department of Intensive Care, 4131, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, 2100, Copenhagen, Denmark. mortenhylander@gmail.com.

PMID: 28238056
DOI: 10.1007/s00134-017-4733-0

No abstract available

Publication types

Review

MeSH terms

Anti-Ulcer Agents / adverse effects
Anti-Ulcer Agents / therapeutic use*
Critical Illness
Histamine H2 Antagonists / adverse effects
Histamine H2 Antagonists / therapeutic use*
Humans
Intensive Care Units
Observational Studies as Topic
Peptic Ulcer Hemorrhage / etiology
Peptic Ulcer Hemorrhage / prevention & control
Practice Guidelines as Topic
Proton Pump Inhibitors / adverse effects
Proton Pump Inhibitors / therapeutic use*
Randomized Controlled Trials as Topic
Risk Factors
Stomach Ulcer / complications
Stomach Ulcer / drug therapy*
Stomach Ulcer / prevention & control*
Stress, Physiological*

Substances

Anti-Ulcer Agents
Histamine H2 Antagonists
Proton Pump Inhibitors